Oraflogo Pro Gel 10 ml product packagingOraflogo® Original Gel
Human HealthProtective topical gel

Oraflogo® Original Gel

A protective topical oral-care gel combining 10 natural active ingredients and hyaluronic acid for general oral-mucosa care.

ConsumerHealthcare professionalDentistPharmacy

Product profile

A defined place in the portfolio.

Original Gel is the general oral-care gel presentation in the Oraflogo® range. The English brochure describes a protective-layer format with 10 natural active ingredients and hyaluronic acid. Its professional references relate to the studied gel rather than to the complete Oral System.

Formulation

Key ingredients and technology

01

10 natural active ingredients

This count is stated for Original Gel in the English range brochure. The complete current ingredient list should be checked on the approved local label.

02

Hyaluronic acid

Explicitly listed for this gel. The range-level concentration and molecular-weight information does not establish a specific concentration for this presentation.

Use and suitability

Follow the instructions on the market-specific product label. Ask a healthcare or dental professional about suitability when needed.

Scientific evidence

Research on the finished formulation.

The brochure identifies Original Gel as the studied product in the following professional dental publications. Their classifications and limitations remain explicit.

Finished-product study

Original Gel · product evaluation

  • Product evaluation
  • Professional dental publication
  • 2014

The brochure attributes favourable user-satisfaction findings to this evaluation of a gel combining hyaluronic acid, herbal extracts and coenzyme Q10. Satisfaction is not the same as demonstrated clinical efficacy.

Study limitations and context

Observational evaluation in 64 patients, assessed by questionnaire and patient opinion. No range-wide efficacy claim is inferred.

Kulis M, Necimer A, Kulis B, Kulis M. “Evaluation of the effect of the combination of hyaluronic acid, herbal extracts and coenzyme Q10 on the soft tissues in the oral cavity.” Dental Tribune. 2014;5(5):12–13.

Finished-product study

Original Gel · pilot comparison

  • Pilot study
  • Oral ulcerative lesions
  • 2018

As summarised in the brochure, a 2018 pilot study reported comparable changes in ulcer-related pain and lesion size between Oraflogo gel and triamcinolone dental paste within the study setting. This relates only to the studied gel, population and study design; it is not a broad corticosteroid-equivalence claim.

Study limitations and context

Pilot study in 22 patients, allocated to two groups of 11 (Oraflogo gel vs triamcinolone acetonide dental paste).

Sever E. “Pilot study comparing triamcinolone acetonide dental paste and Oraflogo gel on oral ulcerative lesions.” Dental Tribune. 2018;2(9):16–19.

Finished-product study

Original Gel · topical-gel evaluation

  • Product evaluation
  • Professional dental publication
  • 2015

The brochure cites an evaluation of topical gel in gum and oral-mucosa care and reproduces comparisons with placebo. These are brochure-reported observations, not evidence of a verified randomised controlled trial or efficacy across the complete range.

Study limitations and context

The full publication is a professional article reviewing published research on the gel's natural ingredients.

Morche W. “Therapeutic effects of a topic gel with hyaluronic acid and the other natural extracts on the healing of gums and oral mucosa.” Dental Spiegel. 2015;6(7):2–6.

References

  1. 1.

    Kulis M, Necimer A, Kulis B, Kulis M. “Evaluation of the effect of the combination of hyaluronic acid, herbal extracts and coenzyme Q10 on the soft tissues in the oral cavity.” Dental Tribune. 2014;5(5):12–13.

  2. 2.

    Sever E. “Pilot study comparing triamcinolone acetonide dental paste and Oraflogo gel on oral ulcerative lesions.” Dental Tribune. 2018;2(9):16–19.

  3. 3.

    Morche W. “Therapeutic effects of a topic gel with hyaluronic acid and the other natural extracts on the healing of gums and oral mucosa.” Dental Spiegel. 2015;6(7):2–6.

These studies are summarised in the professional brochure, and the full original publications are available below as professional resources. Study design, participants and outcomes must be interpreted in their original context. Findings for a studied gel do not establish efficacy for other Oraflogo formats or equivalence to corticosteroids. The approved market-specific label remains authoritative.

Professional resources

Professional materials

Clinical & product studies

First page of the Sever 2018 pilot study on oral ulcerative lesions
Comparative pilot study

Pilot study comparing triamcinolone acetonide dental paste and Oraflogo gel on oral ulcerative lesions

Sever E., 2018. Comparative pilot study in 22 patients with oral ulcers, allocated to two groups of 11: one applied Oraflogo gel, the other triamcinolone acetonide dental paste (a topical corticosteroid). Pain and ulcer size were evaluated.

PDF · Original publication · English

First page of the Kulis 2014 study on oral soft tissues
Product study · Observational

Evaluation of the effect of the combination of hyaluronic acid, herbal extracts and coenzyme Q10 on the soft tissues in the oral cavity

Kulis M., Necimer A., Kulis B., Kulis M., 2014. Observational product study in 64 patients with oral ulcerations, periodontal conditions or post-extraction care, assessed by questionnaire and patient opinion compared with previously used products.

PDF · Original publication · English

Scientific / professional articles

First page of the Morche 2015 professional article
Professional article

Therapeutic effects of a topical gel with hyaluronic acid and other natural extracts on the healing of gums and oral mucosa

Dr. Wolfgang Morche, 2015. Professional article reviewing published research on natural ingredients found in Oraflogo gel in the context of oral soft-tissue care.

PDF · Professional article · English

Responsible information

Science, quality and context.

This portfolio overview is not medical advice. Always refer to the approved label in your market and consult an appropriate healthcare professional when needed.

These studies are summarised in the professional brochure, and the full original publications are available below as professional resources. Study design, participants and outcomes must be interpreted in their original context. Findings for a studied gel do not establish efficacy for other Oraflogo formats or equivalence to corticosteroids. The approved market-specific label remains authoritative.

Interested in Oraflogo® Original Gel?

Ask about local availability, professional information or distribution opportunities.

Request Product Information